nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Abnormal pigmentation—Temozolomide—skin cancer	0.105	0.105	CcSEcCtD
Propericiazine—Amenorrhoea—Vismodegib—skin cancer	0.0358	0.0358	CcSEcCtD
Propericiazine—Pigmentation disorder—Temozolomide—skin cancer	0.0298	0.0298	CcSEcCtD
Propericiazine—Traumatic liver injury—Temozolomide—skin cancer	0.0267	0.0267	CcSEcCtD
Propericiazine—Altered state of consciousness—Temozolomide—skin cancer	0.0215	0.0215	CcSEcCtD
Propericiazine—Hypokalaemia—Vismodegib—skin cancer	0.0208	0.0208	CcSEcCtD
Propericiazine—Parkinsonism—Fluorouracil—skin cancer	0.0202	0.0202	CcSEcCtD
Propericiazine—Sudden death—Fluorouracil—skin cancer	0.0179	0.0179	CcSEcCtD
Propericiazine—Deep vein thrombosis—Temozolomide—skin cancer	0.0163	0.0163	CcSEcCtD
Propericiazine—Photosensitivity—Vemurafenib—skin cancer	0.0161	0.0161	CcSEcCtD
Propericiazine—Menorrhagia—Temozolomide—skin cancer	0.0134	0.0134	CcSEcCtD
Propericiazine—Aggression—Bleomycin—skin cancer	0.0134	0.0134	CcSEcCtD
Propericiazine—Nasal congestion—Imiquimod—skin cancer	0.0132	0.0132	CcSEcCtD
Propericiazine—Eosinophilia—Vemurafenib—skin cancer	0.0121	0.0121	CcSEcCtD
Propericiazine—Menstruation irregular—Docetaxel—skin cancer	0.0119	0.0119	CcSEcCtD
Propericiazine—Liver injury—Temozolomide—skin cancer	0.0118	0.0118	CcSEcCtD
Propericiazine—Amenorrhoea—Temozolomide—skin cancer	0.0113	0.0113	CcSEcCtD
Propericiazine—Photosensitivity reaction—Vemurafenib—skin cancer	0.0111	0.0111	CcSEcCtD
Propericiazine—Deep vein thrombosis—Docetaxel—skin cancer	0.0109	0.0109	CcSEcCtD
Propericiazine—Sweating increased—Imiquimod—skin cancer	0.0101	0.0101	CcSEcCtD
Propericiazine—Pulmonary embolism—Temozolomide—skin cancer	0.00994	0.00994	CcSEcCtD
Propericiazine—Constipation—Vismodegib—skin cancer	0.00961	0.00961	CcSEcCtD
Propericiazine—Erectile dysfunction—Imiquimod—skin cancer	0.00959	0.00959	CcSEcCtD
Propericiazine—Photosensitivity reaction—Imiquimod—skin cancer	0.0095	0.0095	CcSEcCtD
Propericiazine—Cardiac disorder—Vemurafenib—skin cancer	0.00907	0.00907	CcSEcCtD
Propericiazine—Nasal congestion—Temozolomide—skin cancer	0.00792	0.00792	CcSEcCtD
Propericiazine—Diarrhoea—Vismodegib—skin cancer	0.00769	0.00769	CcSEcCtD
Propericiazine—Photosensitivity—Fluorouracil—skin cancer	0.00757	0.00757	CcSEcCtD
Propericiazine—Amenorrhoea—Docetaxel—skin cancer	0.00753	0.00753	CcSEcCtD
Propericiazine—Arrhythmia—Imiquimod—skin cancer	0.00744	0.00744	CcSEcCtD
Propericiazine—Vomiting—Vismodegib—skin cancer	0.00714	0.00714	CcSEcCtD
Propericiazine—Rash—Vismodegib—skin cancer	0.00708	0.00708	CcSEcCtD
Propericiazine—Dermatitis—Vismodegib—skin cancer	0.00708	0.00708	CcSEcCtD
Propericiazine—Infection—Vemurafenib—skin cancer	0.0069	0.0069	CcSEcCtD
Propericiazine—Nausea—Vismodegib—skin cancer	0.00667	0.00667	CcSEcCtD
Propericiazine—Agitation—Imiquimod—skin cancer	0.00667	0.00667	CcSEcCtD
Propericiazine—Pneumonia—Bleomycin—skin cancer	0.00663	0.00663	CcSEcCtD
Propericiazine—Angioedema—Imiquimod—skin cancer	0.00663	0.00663	CcSEcCtD
Propericiazine—Pulmonary embolism—Docetaxel—skin cancer	0.00661	0.00661	CcSEcCtD
Propericiazine—Hypokalaemia—Temozolomide—skin cancer	0.00657	0.00657	CcSEcCtD
Propericiazine—Hypotension—Vemurafenib—skin cancer	0.00649	0.00649	CcSEcCtD
Propericiazine—Pneumonia—Dactinomycin—skin cancer	0.00619	0.00619	CcSEcCtD
Propericiazine—Sweating increased—Temozolomide—skin cancer	0.00608	0.00608	CcSEcCtD
Propericiazine—Dry mouth—Imiquimod—skin cancer	0.00604	0.00604	CcSEcCtD
Propericiazine—Constipation—Vemurafenib—skin cancer	0.00594	0.00594	CcSEcCtD
Propericiazine—Oedema—Imiquimod—skin cancer	0.00592	0.00592	CcSEcCtD
Propericiazine—Infection—Imiquimod—skin cancer	0.00588	0.00588	CcSEcCtD
Propericiazine—Tachycardia—Imiquimod—skin cancer	0.00578	0.00578	CcSEcCtD
Propericiazine—Erectile dysfunction—Temozolomide—skin cancer	0.00575	0.00575	CcSEcCtD
Propericiazine—Agranulocytosis—Dactinomycin—skin cancer	0.00574	0.00574	CcSEcCtD
Propericiazine—Hyperhidrosis—Imiquimod—skin cancer	0.00572	0.00572	CcSEcCtD
Propericiazine—Photosensitivity reaction—Temozolomide—skin cancer	0.00569	0.00569	CcSEcCtD
Propericiazine—Eosinophilia—Fluorouracil—skin cancer	0.00569	0.00569	CcSEcCtD
Propericiazine—Weight increased—Temozolomide—skin cancer	0.00568	0.00568	CcSEcCtD
Propericiazine—Hyperglycaemia—Temozolomide—skin cancer	0.00563	0.00563	CcSEcCtD
Propericiazine—Pneumonia—Temozolomide—skin cancer	0.00559	0.00559	CcSEcCtD
Propericiazine—Body temperature increased—Vemurafenib—skin cancer	0.00549	0.00549	CcSEcCtD
Propericiazine—Insomnia—Imiquimod—skin cancer	0.00535	0.00535	CcSEcCtD
Propericiazine—Dyspnoea—Imiquimod—skin cancer	0.00528	0.00528	CcSEcCtD
Propericiazine—Somnolence—Imiquimod—skin cancer	0.00526	0.00526	CcSEcCtD
Propericiazine—Photosensitivity reaction—Fluorouracil—skin cancer	0.00525	0.00525	CcSEcCtD
Propericiazine—Pneumonia—Fluorouracil—skin cancer	0.00515	0.00515	CcSEcCtD
Propericiazine—Hypersensitivity—Vemurafenib—skin cancer	0.00511	0.00511	CcSEcCtD
Propericiazine—Agranulocytosis—Fluorouracil—skin cancer	0.00478	0.00478	CcSEcCtD
Propericiazine—Diarrhoea—Vemurafenib—skin cancer	0.00475	0.00475	CcSEcCtD
Propericiazine—Body temperature increased—Imiquimod—skin cancer	0.00468	0.00468	CcSEcCtD
Propericiazine—Cardiac disorder—Temozolomide—skin cancer	0.00463	0.00463	CcSEcCtD
Propericiazine—Vomiting—Vemurafenib—skin cancer	0.00441	0.00441	CcSEcCtD
Propericiazine—Rash—Vemurafenib—skin cancer	0.00438	0.00438	CcSEcCtD
Propericiazine—Dermatitis—Vemurafenib—skin cancer	0.00437	0.00437	CcSEcCtD
Propericiazine—Hypersensitivity—Imiquimod—skin cancer	0.00436	0.00436	CcSEcCtD
Propericiazine—Confusional state—Bleomycin—skin cancer	0.00424	0.00424	CcSEcCtD
Propericiazine—Oedema—Bleomycin—skin cancer	0.00421	0.00421	CcSEcCtD
Propericiazine—Infection—Bleomycin—skin cancer	0.00418	0.00418	CcSEcCtD
Propericiazine—Nausea—Vemurafenib—skin cancer	0.00412	0.00412	CcSEcCtD
Propericiazine—Arrhythmia—Fluorouracil—skin cancer	0.00411	0.00411	CcSEcCtD
Propericiazine—Vision blurred—Temozolomide—skin cancer	0.0041	0.0041	CcSEcCtD
Propericiazine—Tremor—Temozolomide—skin cancer	0.00407	0.00407	CcSEcCtD
Propericiazine—Diarrhoea—Imiquimod—skin cancer	0.00405	0.00405	CcSEcCtD
Propericiazine—Agitation—Temozolomide—skin cancer	0.00399	0.00399	CcSEcCtD
Propericiazine—Angioedema—Temozolomide—skin cancer	0.00397	0.00397	CcSEcCtD
Propericiazine—Hypotension—Bleomycin—skin cancer	0.00393	0.00393	CcSEcCtD
Propericiazine—Oedema—Dactinomycin—skin cancer	0.00392	0.00392	CcSEcCtD
Propericiazine—Infection—Dactinomycin—skin cancer	0.0039	0.0039	CcSEcCtD
Propericiazine—Weight increased—Docetaxel—skin cancer	0.00378	0.00378	CcSEcCtD
Propericiazine—Vision blurred—Fluorouracil—skin cancer	0.00377	0.00377	CcSEcCtD
Propericiazine—Vomiting—Imiquimod—skin cancer	0.00376	0.00376	CcSEcCtD
Propericiazine—Dyspnoea—Bleomycin—skin cancer	0.00375	0.00375	CcSEcCtD
Propericiazine—Rash—Imiquimod—skin cancer	0.00373	0.00373	CcSEcCtD
Propericiazine—Dermatitis—Imiquimod—skin cancer	0.00373	0.00373	CcSEcCtD
Propericiazine—Pneumonia—Docetaxel—skin cancer	0.00372	0.00372	CcSEcCtD
Propericiazine—Dry mouth—Temozolomide—skin cancer	0.00362	0.00362	CcSEcCtD
Propericiazine—Jaundice—Docetaxel—skin cancer	0.00361	0.00361	CcSEcCtD
Propericiazine—Confusional state—Temozolomide—skin cancer	0.00358	0.00358	CcSEcCtD
Propericiazine—Oedema—Temozolomide—skin cancer	0.00355	0.00355	CcSEcCtD
Propericiazine—Infection—Temozolomide—skin cancer	0.00352	0.00352	CcSEcCtD
Propericiazine—Nausea—Imiquimod—skin cancer	0.00352	0.00352	CcSEcCtD
Propericiazine—Agranulocytosis—Docetaxel—skin cancer	0.00345	0.00345	CcSEcCtD
Propericiazine—Hyperhidrosis—Temozolomide—skin cancer	0.00343	0.00343	CcSEcCtD
Propericiazine—Body temperature increased—Bleomycin—skin cancer	0.00332	0.00332	CcSEcCtD
Propericiazine—Confusional state—Fluorouracil—skin cancer	0.0033	0.0033	CcSEcCtD
Propericiazine—Oedema—Fluorouracil—skin cancer	0.00327	0.00327	CcSEcCtD
Propericiazine—Infection—Fluorouracil—skin cancer	0.00325	0.00325	CcSEcCtD
Propericiazine—Insomnia—Temozolomide—skin cancer	0.00321	0.00321	CcSEcCtD
Propericiazine—Tachycardia—Fluorouracil—skin cancer	0.00319	0.00319	CcSEcCtD
Propericiazine—Dyspnoea—Temozolomide—skin cancer	0.00316	0.00316	CcSEcCtD
Propericiazine—Somnolence—Temozolomide—skin cancer	0.00315	0.00315	CcSEcCtD
Propericiazine—Body temperature increased—Dactinomycin—skin cancer	0.0031	0.0031	CcSEcCtD
Propericiazine—Hypersensitivity—Bleomycin—skin cancer	0.0031	0.0031	CcSEcCtD
Propericiazine—Cardiac disorder—Docetaxel—skin cancer	0.00308	0.00308	CcSEcCtD
Propericiazine—Hypotension—Fluorouracil—skin cancer	0.00305	0.00305	CcSEcCtD
Propericiazine—Constipation—Temozolomide—skin cancer	0.00303	0.00303	CcSEcCtD
Propericiazine—Arrhythmia—Docetaxel—skin cancer	0.00297	0.00297	CcSEcCtD
Propericiazine—Insomnia—Fluorouracil—skin cancer	0.00296	0.00296	CcSEcCtD
Propericiazine—Dyspnoea—Fluorouracil—skin cancer	0.00291	0.00291	CcSEcCtD
Propericiazine—Somnolence—Fluorouracil—skin cancer	0.00291	0.00291	CcSEcCtD
Propericiazine—Hypersensitivity—Dactinomycin—skin cancer	0.00289	0.00289	CcSEcCtD
Propericiazine—Body temperature increased—Temozolomide—skin cancer	0.0028	0.0028	CcSEcCtD
Propericiazine—Diarrhoea—Dactinomycin—skin cancer	0.00268	0.00268	CcSEcCtD
Propericiazine—Vomiting—Bleomycin—skin cancer	0.00267	0.00267	CcSEcCtD
Propericiazine—Rash—Bleomycin—skin cancer	0.00265	0.00265	CcSEcCtD
Propericiazine—Dermatitis—Bleomycin—skin cancer	0.00265	0.00265	CcSEcCtD
Propericiazine—Hypersensitivity—Temozolomide—skin cancer	0.00261	0.00261	CcSEcCtD
Propericiazine—Body temperature increased—Fluorouracil—skin cancer	0.00258	0.00258	CcSEcCtD
Propericiazine—Nausea—Bleomycin—skin cancer	0.0025	0.0025	CcSEcCtD
Propericiazine—Vomiting—Dactinomycin—skin cancer	0.00249	0.00249	CcSEcCtD
Propericiazine—Rash—Dactinomycin—skin cancer	0.00247	0.00247	CcSEcCtD
Propericiazine—Diarrhoea—Temozolomide—skin cancer	0.00243	0.00243	CcSEcCtD
Propericiazine—Hypersensitivity—Fluorouracil—skin cancer	0.00241	0.00241	CcSEcCtD
Propericiazine—Dry mouth—Docetaxel—skin cancer	0.00241	0.00241	CcSEcCtD
Propericiazine—Confusional state—Docetaxel—skin cancer	0.00238	0.00238	CcSEcCtD
Propericiazine—Oedema—Docetaxel—skin cancer	0.00236	0.00236	CcSEcCtD
Propericiazine—Infection—Docetaxel—skin cancer	0.00234	0.00234	CcSEcCtD
Propericiazine—Nausea—Dactinomycin—skin cancer	0.00233	0.00233	CcSEcCtD
Propericiazine—Tachycardia—Docetaxel—skin cancer	0.0023	0.0023	CcSEcCtD
Propericiazine—Vomiting—Temozolomide—skin cancer	0.00226	0.00226	CcSEcCtD
Propericiazine—Rash—Temozolomide—skin cancer	0.00224	0.00224	CcSEcCtD
Propericiazine—Diarrhoea—Fluorouracil—skin cancer	0.00224	0.00224	CcSEcCtD
Propericiazine—Dermatitis—Temozolomide—skin cancer	0.00223	0.00223	CcSEcCtD
Propericiazine—Hypotension—Docetaxel—skin cancer	0.0022	0.0022	CcSEcCtD
Propericiazine—Insomnia—Docetaxel—skin cancer	0.00213	0.00213	CcSEcCtD
Propericiazine—Nausea—Temozolomide—skin cancer	0.00211	0.00211	CcSEcCtD
Propericiazine—Dyspnoea—Docetaxel—skin cancer	0.0021	0.0021	CcSEcCtD
Propericiazine—Somnolence—Docetaxel—skin cancer	0.0021	0.0021	CcSEcCtD
Propericiazine—Vomiting—Fluorouracil—skin cancer	0.00208	0.00208	CcSEcCtD
Propericiazine—Rash—Fluorouracil—skin cancer	0.00206	0.00206	CcSEcCtD
Propericiazine—Dermatitis—Fluorouracil—skin cancer	0.00206	0.00206	CcSEcCtD
Propericiazine—Constipation—Docetaxel—skin cancer	0.00202	0.00202	CcSEcCtD
Propericiazine—Nausea—Fluorouracil—skin cancer	0.00194	0.00194	CcSEcCtD
Propericiazine—Body temperature increased—Docetaxel—skin cancer	0.00186	0.00186	CcSEcCtD
Propericiazine—Hypersensitivity—Docetaxel—skin cancer	0.00174	0.00174	CcSEcCtD
Propericiazine—Diarrhoea—Docetaxel—skin cancer	0.00161	0.00161	CcSEcCtD
Propericiazine—Vomiting—Docetaxel—skin cancer	0.0015	0.0015	CcSEcCtD
Propericiazine—Rash—Docetaxel—skin cancer	0.00149	0.00149	CcSEcCtD
Propericiazine—Dermatitis—Docetaxel—skin cancer	0.00149	0.00149	CcSEcCtD
Propericiazine—Nausea—Docetaxel—skin cancer	0.0014	0.0014	CcSEcCtD
